BCRX – biocryst pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
BioCryst Launches ORLADEYO® (berotralstat) in Ireland [Yahoo! Finance]
BioCryst Launches ORLADEYO® (berotralstat) in Ireland
BioCryst to Present at Upcoming Investor Conferences
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $10.00 price target on the stock.
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: VANGUARD GROUP INC
Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: VANGUARD GROUP INC
Form 10-Q BIOCRYST PHARMACEUTICALS For: Sep 30
Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: VANGUARD GROUP INC
Form 8-K BIOCRYST PHARMACEUTICALS For: Nov 04
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.